[Jefferson Home] [Hospital] [Jefferson Pulse] [Employment] [Contact Us] [Search] [News]

TJU | JMC logo
The Bottom Line: Achieving Diabetes Treatment Goals
VOLUME 1 ISSUE 1
CASE KM
CASE KM
EDITORS
CME INFORMATION
DISCLAIMER
REFERENCES
VOLUME 1 ISSUE 2
CASE WM
VOLUME 1 ISSUE 3
CASE SW
VOLUME 1 ISSUE 4
CASE JJ
VOLUME 1 ISSUE 5
CASE PD
VOLUME 1 ISSUE 6
CASE MP


REFERENCES

VOLUME 1 ISSUE 1 CASE KM

  1. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report, 2000. Available at: http://www.nhlbi.nih.gov/guidelines/obesity/ob_home.htm

  2. American Diabetes Association. Clinical Practice Recommendations 2003. Diabetes Care 2003;26:1 156. Available at: http://www.diabetes.org

  3. National Heart, Lung, and Blood Institute. Third report of the National Cholesterol Education Program (NCEP) on detection, evaluation, and treatment of high blood cholesterol in adults (ATP III). Executive Summary. NIH Publication 01-3670, May 2001. Available at: http://www.nhlbi.nih.gov/guidelines/cholesterol/

  4. American Association of Clinical Endocrinologists. American College of Endocrinology Consensus Statement on Guidelines for Glycemic Control. Endocrine Pract 2002;8(suppl 1)5–11. Available at: http://www.aace.com/pub/dcc/dccwhitepaper.pdf

  5. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot 1997;12:38–48.

  6. UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854–865.

  7. Moneva MH, Dagogo-Jack S. Multiple drug targets in the management of type 2 diabetes. Current Drug Targets 2002;3:203–221.

  8. Gæde P, Vedel P Larsen N, et al. Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes. N Engl J Med 2003;348:383–393.

  9. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977–986.

  10. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853.

  11. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103–117.

THIS ACTIVITY IS SUPPORTED BY AN UNRESTRICTED EDUCATIONAL GRANT FROM
JOINTLY SPONSORED BY  |  TJU | JMC logo  |  BIOCENTRIC INC logo


The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.

Return to Thomas Jefferson University Home Page